Women's Health Diagnostics Market Size Worth $76.2 Billion by 2025: Grand View Research, Inc.

SAN FRANCISCO, December 12, 2018 /PRNewswire/ --

The global women's health diagnostics market size is expected to reach USD 76.2 billion by 2025, according to a new report by Grand View Research, Inc. Rising adoption of point-of-care diagnostics and growing incidence of various chronic and lifestyle diseases are among the key factors stimulating the growth of the market. Besides this, introducing various awareness programs is also anticipated to work in favor the market during the forecast period. For instance, in 2014, the European Commission launched joint action for European Guide on Quality Improvement in Comprehensive Cancer Control.

     (Logo: https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg )

Women's health diagnostics is witnessing high growth due to increased funding from various organizations. For instance, in May 2015, Abcodia received funding of USD 8.0 million from Cambridge Innovative Capital, Scottish Equity Partners, Albion Ventures, and UCLB to launch Risk of Ovarian Cancer Algorithm (ROCA) test in the U.K. for early detection of ovarian cancer.

On the basis of end use, the market has been bifurcated into hospital & diagnostics centers and home. Hospitals and diagnostic centers accounted for a larger share in the market due to high number of visits to hospitals and more reliable detection.

The market in Asia Pacific is likely to witness significant growth over the coming years. The growth of the market can be attributed to increasing investments in healthcare, growing focus of international device manufacturers on strengthening their distribution networks within the region, and epidemiological shift from infectious diseases to chronic diseases within regional boundaries.

Browse full research report with TOC on "Women's Health Diagnostics Market Size, Share & Trends Analysis Report By End Use, By Application (Cancer, Infectious Disease, Osteoporosis, Pregnancy, Prenatal), and Segment Forecasts, 2018 - 2025" at: https://www.grandviewresearch.com/industry-analysis/womens-health-diagnostics-market

Further Key Findings From the Report Suggest: 

• Increasing investments by governments and private bodies and rising disposable income are providing a push to the market
• Cancer accounted for the highest share in the market in 2017. The segment will register noteworthy growth during the forecast period owing to availability of early detection tests and government initiatives to tackle cancer
• Prenatal testing is estimated to be the fastest growing segment during the same period owing to rising prevalence of prenatal diseases, increasing maternal age, surging healthcare expenditure, and development of advanced diagnostic tests
• Geographically, North America was the leading revenue contributor to the women's health diagnostics market in 2017. It is anticipated to maintain its dominance through 2025, thanks to widening base of diagnostic and imaging centers, mounting cases of cancer, growing awareness about fertility testing, and spiraling adoption of point-of-care testing devices
• Some of the key players are Siemens Healthcare Private Limited; Hologic, Inc.;GE Healthcare; F. Hoffmann-La Roche Ltd.; bioMérieux SA; Koninklijke Philips N.V; Abbott; Becton, Dickinson and Company, Quest Diagnostics, Inc.; and PerkinElmer, Inc.

Browse related reports by Grand View Research: 

• Nucleic Acid Amplification Testing Market - The global nucleic acid amplification testing (NAAT) market size was valued at USD 1.78 billion in 2015. 
  
• Kidney Function Tests Market - The global kidney function tests market size was valued at USD 1.2 billion in 2016 and is expected to grow at a CAGR of 5.2% over the forecast period. 
  
• Cancer Diagnostics Market - The global cancer diagnostics market size was valued at USD 124.0 billion in 2016 and is expected to grow at a CAGR of 7.2% over the forecast period.
  
• Blood Culture Test Market - The global blood culture test market size was estimated at USD 3.2 billion in 2016.

Grand View Research has segmented the global women's health diagnostics market based on application, end use, and region: 

• Women's Health Diagnostics Application Outlook (Revenue, USD Million, 2014 - 2025) 
  • Cancer
    • Breast Cancer Testing
    • Cervical Cancer Testing
    • Ovarian Cancer Testing
  • Infectious Disease Testing
  • Osteoporosis Testing
  • Pregnancy and Fertility Testing
  • Prenatal Testing
• Women's Health Diagnostics End Use Outlook (Revenue, USD Million, 2014 - 2025) 
  • Hospital and Diagnostics Centers
  • Home
• Women's Health Diagnostics Regional Outlook (Revenue, USD Million, 2014 - 2025) 
  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
  • Asia Pacific
    • Japan
    • China
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • South Africa

Explore the BI enabled intuitive market research database, Grand View Compass, by Grand View Research, Inc.

About Grand View Research 

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: +1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com